Key Documents

View All Documentation

593168

Ethyl 3,4-dimethoxybenzoylacetate

Name: Ethyl 3,4-dimethoxybenzoylacetate
Brand: ALDRICH

97%

Select a Size

Change View

About This Item

Linear Formula:

C₂H₅OCOCH₂COC₆H₃(OCH₃)₂

CAS Number:

4687-37-0

Molecular Weight:

252.26

NACRES:

NA.22

PubChem Substance ID:

24881333

UNSPSC Code:

12352100

MDL number:

MFCD03424826

Assay:

97%

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Quality Level

200

assay

97%

mp

37-41 °C (lit.)

functional group

ester, ketone

SMILES string

CCOC(=O)CC(=O)c1ccc(OC)c(OC)c1

InChI

1S/C13H16O5/c1-4-18-13(15)8-10(14)9-5-6-11(16-2)12(7-9)17-3/h5-7H,4,8H2,1-3H3

InChI key

BHSYONGONOKNAI-UHFFFAOYSA-N

Description

pictograms

GHS07

signalword

Warning

hcodes

H302

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

>230.0 °F - closed cup

flash_point_c

> 110 °C - closed cup

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

0000562523

0000396921

0000176338

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Nanostructured ultra-thin patches for ultrasound-modulated delivery of anti-restenotic drug.

Lorenzo Vannozzi et al.

International journal of nanomedicine, 11, 69-91 (2016-01-06)

This work aims to demonstrate the possibility to fabricate ultra-thin polymeric films loaded with an anti-restenotic drug and capable of tunable drug release kinetics for the local treatment of restenosis. Vascular nanopatches are composed of a poly(lactic acid) supporting membrane

Cyclodextrin-based nanosponges for the targeted delivery of the anti-restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention.

Vito Coviello et al.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 117, 276-285 (2017-05-01)

Nano-sized colloidal carriers represent innovative drug delivery systems, as they allow a targeted and prolonged release of poorly water-soluble drugs, improving their bioavailability and modifying their pharmacokinetic parameters. In this work we describe cyclodextrin-based nanosponges, obtained through polimerization of β-cyclodextrin

Global Trade Item Number

SKU	GTIN
593168-1G	04061825586618
593168-5G	04061831821925